Answers are grounded in this paper and cite their sources.
A total of 88 weanling pigs (241 × 600 DNA; initially 14.0 lb) were used in a 28-d study using two groups of pigs (44 pigs/group) to evaluate the effects of a silicic acid (SA) and short-chain fructo-oligosaccharide (FOS) feed additive with or without pharmacological levels of zinc (Zn) from zinc oxide on growth performance and fecal dry matter (DM) in enterotoxigenic Escherichia coli F18 (ETEC) challenged nursery pigs. Within group, pigs were weaned and randomly allotted to one of four dietary treatments in a completely randomized design. There were 22 pigs per dietary treatment, and diets were fed in two phases with phase 1 being fed from d 0 to 10 after weaning, and phase 2 being fed from d 10 after weaning until the conclusion of the trial on d 28 after weaning. The four dietary treatments were arranged in a 2 × 2 factorial with main effects of SA/FOS feed additive (none or 0.5 lb/ton of complete feed; Improx, Addix Biotech, Weston, FL) and pharmacological levels of Zn from ZnO (no supplemental Zn from ZnO or 2,990 mg/kg added in phase 1 and 2,018 mg/kg in phase 2). All diets contained 110 mg/kg Zn from the base trace mineral premix. Pigs were group-housed for a 14-d acclimation period after weaning, then moved to individual pens and inoculated with 6 mL of solution containing approximately 107 CFU/mL of ETEC F18 administered via orogastric gavage with a rubber catheter. During period 1 after inoculation (d 14 to 17 after weaning), an SA/FOS × pharmacological Zn interaction was observed for ADG (P = 0.027), resulting from no difference when pigs were fed pharmacological levels of Zn with or without SA/FOS; however, without pharmacological levels of Zn, supplementing SA/FOS improved (P < 0.05) ADG. Overall, pharmacological levels of Zn improved d 28 BW, ADG, and ADFI (P < 0.001). A SA/FOS × day interaction was observed (P = 0.050) for fecal DM, with a significant decrease in fecal DM on d 21 (P = 0.023) in pigs fed SA/FOS, but no significant differences on other days. There was a significant Zn × day interactive effect (P = 0.034) for fecal DM with an increase in fecal DM on d 17, 21, and 28 (P ≤ 0.009) in pigs fed pharmacological levels of Zn but no significant differences on d 10 or 14. For the cytokine analysis, a significant SA/FOS × pharmacological Zn × day interaction was observed (P = 0.032; Table 4) for IL-1β, where an SA/FOS × pharmacological Zn interaction was observed on d 21 (P = 0.030), resulting from a reduction when pigs were fed pharmacological levels of Zn without SA/FOS; however, with SA/FOS, pharmacological levels of Zn increased IL-1β, with no significant differences observed on other days. In conclusion, an interactive effect was observed in period 1 on ADG, resulting from no difference in ADG when pigs were fed pharmacological levels of Zn with or without SA/FOS; however, without pharmacological levels of Zn, supplementing SA/FOS improved ADG. The combination of SA/FOS and Zn marginally increased pro-inflammatory and anti-inflammatory cytokines during the study. Treatment differences were observed in survival probability by day after pigs were inoculated with enterotoxigenic Escherichia coli, with survival probability lower for pigs fed the control diet compared with other treatments. Overall, pigs fed pharmacological levels of Zn had improved ADG, ADFI, and fecal DM throughout the study.
No takes yet. Share an insight, caveat, or question.
Knoy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: